ARTICLE | Clinical News
Lower dose submicron diclofenac regulatory update
March 11, 2013 7:00 AM UTC
Iroko said FDA accepted for review an NDA for lower dose submicron diclofenac to treat mild to moderate acute pain in adults. The company declined to disclose the PDUFA date or the date it submitted t...